Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds.
THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
The Doctors and Drugs in Medicare Part D
By Jeff Larson, Jennifer LaFleur, Charles Ornstein, Tracy Weber and Lena Groeger
ProPublica, Updated at May 10, 2013
Medicare’s popular prescription-drug program now serves more than 35 million people, but the names of prescribers and the drugs they choose have never previously been public … Until now.
###
Assessment
Use this tool to find and compare doctors and other top prescribers in 2010.
Link: http://projects.propublica.org/checkup/
More:
- FAQ: What You Need to Know About Prescriber Checkup
- Solutions: Eight Ways to Strengthen Medicare’s Drug Benefit
- Editors’ Note: Lifting the Veil on Dangerous Prescribing
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
****
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
- DICTIONARIES: http://www.springerpub.com/Search/marcinko
- PHYSICIANS: www.MedicalBusinessAdvisors.com
- PRACTICES: www.BusinessofMedicalPractice.com
- HOSPITALS: http://www.crcpress.com/product/isbn/9781466558731
- CLINICS: http://www.crcpress.com/product/isbn/9781439879900
- ADVISORS: www.CertifiedMedicalPlanner.org
- BLOG: www.MedicalExecutivePost.com
- FINANCE: Financial Planning for Physicians and Advisors
- INSURANCE: Risk Management and Insurance Strategies for Physicians and Advisors
Share this:
Filed under: Drugs and Pharma | Tagged: Medicare Part D, prescription drugs, ProPublica Launches Prescriber Checkup |
The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants 
A Rap Sheet For Medicare’s Prescription Drug Program
An update on the new events since the Prescriber Checkup investigation.
http://www.propublica.org/article/a-rap-sheet-for-medicares-prescription-drug-program
Ann Miller RN MHA
LikeLike
Deadline to Check Industry Payments to Docs Fast Approaching
Physicians have until August 27 to review and challenge what drug and device makers have reported giving to them by way of cash or gifts as part of the government’s Open Payments program. They should brace themselves for possible online headaches.
The Open Payments program was established by a subsection of the Affordable Care Act called the Physician Payment Sunshine Act. It is designed to discourage physicians from embroiling themselves in conflicts of interest that might corrupt clinical decision-making, research, and education. Under the Sunshine Act, drug and device makers must inform the Centers for Medicare & Medicaid Services (CMS) of any “transfer of value” of $10 or more to physicians. If transfers of value under $10 add up to more than $100 a year, that is reportable too, as are ownership stakes in drug and device makers.
Source: Robert Lowes, Medscape News [7/25/14]
LikeLike